Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > 1次抗体

Anti-Mouse ALOX12 Polyclonal Antibody (MB621014)

価格(USD):
スペック:
  • 50ug
  • 100ug
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号MB621014
説明
Anti-Mouse ALOX12 Polyclonal Antibody (MB621014) is a rabbit polyclonal antibody detecting Alox12 in ELISA, IHC, WB. Suitable for Mouse.
Highlights
  • ●Affinity Purified — Minimal background and high purity for reliable results.
  • ●Multi-Application — Validated across multiple applications.
種反応性Mouse, Rat
アプリケーションELISA, IHC, WB
宿主種Rabbit
クローン性Polyclonal
アイソタイプIgG
免疫原 E. coli - derived recombinant Mouse ALOX12 (Met1-His167).
ターゲット Polyunsaturated fatty acid lipoxygenase ALOX12, 1.13.11.-, Arachidonate (12S)-lipoxygenase, 12S-LOX, 12S-lipoxygenase, 1.13.11.31, Arachidonate (15S)-lipoxygenase, 1.13.11.33, Linoleate (13S)-lipoxygenase, Lipoxin synthase 12-LO, 3.3.2.-, Platelet-type lipoxygenase 12, P-12LO, Alox12, Alox12p
精製 Purified by antigen affinity column.
アクセッション番号 P39655
形態 Liquid
保存バッファー 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

製品使用情報
アプリケーション 希釈
ELISA 1:5000-1:20000
IHC 1:50-1:500
WB 1:500-1:2000
安定性と保存 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
背景

Polyunsaturated fatty acid lipoxygenase ALOX12 is a ~75 kDa protein. Catalyzes the regio and stereo-specific incorporation of molecular oxygen into free and esterified polyunsaturated fatty acids generating lipid hydroperoxides that can be further reduced to the corresponding hydroxy species. Mainly converts arachidonate ((5Z,8Z,11Z,14Z)-eicosatetraenoate) to the specific bioactive lipid (12S)-hydroperoxyeicosatetraenoate/(12S)-HPETE. Through the production of bioactive lipids like (12S)-HPETE it regulates different biological processes including platelet activation. It can also catalyze the epoxidation of double bonds of polyunsaturated fatty acids such as (14S)-hydroperoxy-docosahexaenoate/(14S)-HPDHA resulting in the formation of (13S,14S)-epoxy-DHA. Furthermore, it may participate in the sequential oxidations of DHA ((4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate) to generate specialized pro-resolving mediators (SPMs) like resolvin D5 ((7S,17S)-diHPDHA) and (7S,14S)-diHPDHA, that actively down-regulate the immune response and have anti-aggregation properties with platelets.

1. Siebert, M. et al. (2001) The Biochemical journal 355, 97-104. PMID: 11256953
2. Teder, T. et al. (2014) Journal of lipid research 55, 2587-96. PMID: 25293588
3. Chen, XS. et al. (1994) The Journal of biological chemistry 269, 13979-87. PMID: 8188678
4. Johnson, EN. et al. (1998) Proceedings of the National Academy of Sciences of the United States of America 95, 3100-5. PMID: 9501222
注意事項 For research use only.
イメージ
参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト